Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and CARISMA Therapeutics (NASDAQ:CARM).
Unicycive Therapeutics has a consensus price target of $5.25.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.4464 last updated September 25, 2024 at 4:00 AM EDT.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.